Abstract
We formerly studied an Italian familiy with apo C-II deficiency. Two probands were homozygous for the defect (immeasurable circulating apolipoprotein C-II and absence of C-II bands on immunoelectrophoresis). We documented the synthesis of the protein at the intestinal level in the probands with immunohistological techniques.
With the purpose of investigating the molecular basis of the defect, Southern analysis, polymerase chain reaction (PCR) amplification and sequence analysis were carried out on one of the two cases. We identified a point mutation C to G transversion in the third exon of the gene causing a premature stop codon. Our hypothesis is that the truncated protein of 36 aa., instead of 79 aa., lacks its functional domain. This causes inefficiency in the activation of lipoprotein lipase (LPL) and the instability of the circulating molecule, which could have an higher catabolic rate compared to a normal protein. The faster disappearance from the circulating compartment make it unmeasurable.
The mutation destroys a Rsa I site, present in the normal gene sequence. We suggest the use of this site for a rapid Restriction Fragment Length Polymorphism (RFLP) on PCR amplification products to screen this defect in the Italian population.
Similar content being viewed by others
References
BaggioG.,ManzatoE.,GabelliC.,FellinR.,MartiniS.,EnziG.B.,VerlatoF.,BaiocchiM.R.,SprecherD.L.,KashyapM.L.,BrewerH.B. andCrepaldiG. (1986): Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity and correction of hypertriglyceridemia after apolipoprotein C-II administration of two affected patients - J. Clin. Invest.17: 520–527.
BreckenridgeW.C.,LittleJ.A.,SteinerG.,ChowA. andPoapstM. (1978): Hypertriglyceridemia associated with deficiency of apolipoprotein C-II - N. Engl. J. Med.298: 1265–1273.
CapursoA.,PaceL.,BonomoL.,CatapanoA.L.,SchiliròG.,LaRosaM. andAssmannG. (1980): New case of apoprotein C-II deficiency - Lancet1: 268.
CapursoA.,MogaveroA.M.,RestaF.,DiTommasoM.,TavernitiR.,TurturroF.,LaRosaM.,MarcovinaS. andCatapanoA.L. (1988): Apolipoprotein C-II deficiency: detection of immunoreactive apolipoprotein C-II in the intestinal mucosa of two patients - J. Lipid Res.29: 703–711.
CatapanoA.L.,MillsG.L.,RomaP.,LaRosaM. andCapursoA. (1983): Plasma lipids, lipoproteins and apolipoproteins in a case of apo C-II deficiency - Clin. Clin. - Acta130: 317–327.
ConnellyP.W.,MaguireG.F.,HofmannT. andLittleJ.A. (1987): Structure of apolipoprotein C-II-Toronto, a nonfunctional human apolipoprotein - Proc. Natl. Acad. Sci. USA84: 270–273.
ConnellyP.W.,MaguireG.F. andLittleJ.A. (1989): Familial chylomicronemia due to mutations in apolipoprotein CII: apolipoprotein CII-Toronto and apolipoprotein CII-St. Michael - In: Sirtori C.R., Franceschini G. - Brewer H.B. - Assmann G. Human apolipoprotein mutants 2 - Plenum Press - New York167: 121–126.
CoxD.W.,BreckenridgeW.C. andLittleJ.A. (1978): Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis - N. Engl. J. Med.299: 1421–1424.
CoxD.W.,WillisD.E.,QuanF. andRayP.N. (1988): A deletion of one nucleotide results in a functional deficiency of apolipoprotein CII (apo C-II Toronto) -J. Med. Gen.25: 649–652.
CrecchioC.,CapursoA. andPepeG. (1990): Identification of the mutation responsible for a case of plasmatic apolipoprotein C-II deficiency (Apo C-II-Bari)- Biochem. Biophys. Res. Commun.168: 1118–1127.
FellinR.,BaggioG.,PoliA.,AugustinJ.,BaiocchiM.R.,BaldoG.,SenigalliaM.,GretenH. andCrepaldiG. (1983): Familial lipoprotein lipase and apoliprotein C-II deficiency - Atherosclerosis49: 55–68.
FojoS.S.,BaggioG.,GabelliC.,HiguchiK.,BojanovskyM.,GreggR.E. andBrewerH.B. (1988): Apolipoprotein C-II deficiency: identification of a structural variant apo C-II-Padova -Biochem. Biophys. Res. Commun.154: 73–79.
FojoS.S.,BeisiegelU.,BeilU.,HiguchiK.,BojanovskyM.,GreggR.E.,GretenH. andBrewerH.B. (1988): Donor splice site mutation in the apolipoprotein (apo) C-II gene (Apo C-II-Hamburg) of a patient with apo C-II deficiency - J. Clin. Invest.82: 1489–1494.
FojoS.S.,deGennesJ.L.,ChapmanJ.,ParrotC.,LohseP.,KwanS.S.,TruffertJ. andBrewerH.B. (1989): An initiation codon mutation in the apo C-II gene (Apo C-II-Paris) of a patient with a deficiency of apolipoprotein C-II - J. Biol. Chem.264: 20389–20842.
FojoS.S.,LawS.W. andBrewerH.B. (1987): The human preproapolipoprotein C-II gene: complete nucleic acid sequence and genomic organization -FEBS Lett.213: 221–226.
FojoS.S.,LohseP.,ParrotC.,BaggioG.,GabelliC.,ThomasF.,HoffmannJ. andBrewerH.B. (1989): A nonsense mutation in the apolipoprotein C-II-Padova gene in a patient with apolipoprotein C-II deficiency - J. Clin. Invest.84: 1215–1219.
FojoS.S.,StalenhoefA.F.H.,MarrK.,GreggR.E. andBrewerH.B. (1988): A deletion mutation in the apo C-II gene (Apo C-II-Nijmegen) of a patient with a deficiency of apolipoprotein C-II - J. Biol. Chem.263: 17913–17916.
GottoA.M. (1984): Apolipoprotein C-II deficiency revisited - N. Engl. J. Med.310: 1664–1665.
HospattankarA.Y.,FairwellT.,RonanR. andBrewerH.B. (1984): Amino acid sequence of human plasma apolipoprotein C-II from normal and hyperlipoproteinemic subjects - J. Biol. Chem.259: 318–322.
JacksonR.L.,BakerH.N.,GilliamE.B. andGottoA.M. (1977): Primary structure of very low density apolipoprotein C-II of human plasma - Proc. Natl. Acad. Sci. USA74: 1942–1945.
KinnunenP.K.J.,JacksonR.L.,SmithL.C.,GottoA.M. andSparrowJ.T. (1977): Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II - Proc. Natl. Acad. Sci. USA74: 4848–4851.
LaRosaJ.C.,LevyI.,HerbertP.,LuxS.E. andFredricksonD.S. (1970): A specific apoprotein activator for lipoprotein lipase - Biochem. Biophys. Res. Commun.41: 45–62.
MillerN.E.,RaoS.N.,AlaupovicP.,NobleN.,SlackJ.,BrunzellJ.D. andLewisB. (1981): Familial apolipoprotein C-II deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion - Eur. J. Clin. Invest.11: 69–76.
SakuK.,CedresC.,McDonaldB.,HyndB.,LiuB.W.,SrivastavaL.S. andKashyapM.L. (1984): C-II anapolipoproteinemia and severe hypertriglyceridemia- Am. J. Med.77: 457–462.
StalenhoefA.F.H.,CasparieA.F.,DemackerP.N.M.,StoutenJ.T.J.,LuttermanJ.A. andvan'tLaarA. (1981): Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia- Metab. Clin. Exp.30: 919–926.
WeiC.F.,TsaoY.K.,RobbersonD.L.,GottoA.M.,BrownK. andChanL. (1985): The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence and identification of 5′ homologous sequences among apolipoprotein genes - J. Biol. Chem.260: 15211–15221.
YamamuraT.,SudoH.,IshikawaK. andYamamotoA. (1979): Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency -Atherosclerosis34: 53–65.
ZannisY.I. andBreslovJ.L. (1985): Genetic mutation affecting human lipoprotein metabolism - In: Harris M. and Hirschhorn K. - Advances in Human Genetics- Plenum Publishing Co. - New York 125–215.
Author information
Authors and Affiliations
Additional information
Corresponding author
Rights and permissions
About this article
Cite this article
Capurso, A., Resta, F., Turturro, F. et al. Apo C-II deficiency type bari. Eur J Epidemiol 8 (Suppl 1), 64–70 (1992). https://doi.org/10.1007/BF00145352
Issue Date:
DOI: https://doi.org/10.1007/BF00145352